Reduction of the toxic effects caused by anthraquinone drugs
US4980149A · kind A · utility
1Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 7, 1985 |
| Grant date | Dec 25, 1990 |
| Priority date | — |
| Expiry date | Aug 7, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The toxic effects caused by anthraquinone drugs, particularly by antitumor anthraquinone drugs, are inhibited or reduced by administering Orgotein in a quantity sufficient to inhibit or reduce the superoxide radicals which are produced by the above mentioned drugs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.